项目基本情况
| 项目名称： | Tight Alright – Connected-health for wounds |
| 项目类型： | New Project |
| 合作方式： | Joint Venture |
| 所属行业： | Scientific Research, Technical Services |
| 项目地点： | Ireland |
| 有效期： | 2 years |
| 项目标注： | General |
| 项目详细地址： | n/a |
| 主要内容： | Project description FeelTect delivers Tight Alright – the first device to use wearable, connected-health technology, combined with a digital platform, for monitoring compression therapy during venous leg ulcer treatment. Venous leg ulcers (VLUs) are chronic wounds that affect 2.3 million people in Europe each year, predominantly those aged over 65 – a population highly susceptible to COVID-19. Compression therapy is the gold-standard treatment for VLUs, however shortages in healthcare personnel due to COVID-19 combined with difficulty in providing safe and effective compression means most VLUs are currently under-served. Tight Alright is a connected-health technology for self-managed compression therapy of VLUs. Economic rationale / Business Model Venous Leg Ulcers (VLUs) are chronic wounds caused by a failure of the veins in the lower legs, affecting 11.5 million people worldwide each year. Compression therapy is the cornerstone of VLU treatment, however it’s extremely difficult to administer consistent levels of safe and efficacious pressure using current compression products. Ineffective therapy causes delayed healing times (20% of VLUs don’t heal within a year) and exorbitant healthcare costs (VLU payer burden in the USA is $14.9 billion). Tight Alright’s ability to enable consistent provision of gold-standard compression therapy and patient self-management has the potential to reduce healing times by 5-weeks and lower costs by €2,600 per patient. FeelTect’s B2B business model will sell Tight Alright technology to healthcare providers via a combination of once-off (reusable electronics) and recurring (disposables, software, data) revenue streams. Initial market traction will be generated through a clinical validation strategy and entry in targeted EU markets. Clinical evidence generated at pilot sites will enable sales growth within those markets, while also providing leverage for premium pricing strategies within lucrative secondary markets including the USA and UK. Financing details Project financing secured: EUR 0.30 million (20 %) Financing source: Private Intended financing will be a combination of private equity and matched funding from local state agencies and European grant instruments. Where appropriate, strategic investment or joint development opportunities will also be considered, as a means of supporting funding requirements and commercial strategies (e.g. distribution channels). The promoter has received / applied for EU / EIB financing support related to this project. Existing or potential bottlenecks for the realisation of the project / Potential risks Risk: Lack of reimbursement. Mitigation: Staged business model to generate post-market evidence for leveraging reimbursement coverage. Risk: Educating providers/patients on rationale for updating a traditional therapy. Mitigation: Strong engagement with KOLs/end-users. Participation in influential advocacy organisations. Health economic analysis within clinical validation plan. Risk: Competitor products. Mitigation: Strong IP protection on wearable compression pressure monitoring device. Project additional information FeelTect began its journey in the renowned BioInnovate Programme in 2016, where CEO Dr Andrew Cameron spent time in University Hospital Galway and Mayo Clinic identifying unmet clinical needs. A critical need was identified for a way to improve the application and maintenance of evidence-based pressure during compression therapy of venous leg ulcers, for improved healing outcomes and quality of life. An Enterprise Ireland Commercialisation Fund began in January 2018 for the development of the Tight Alright technology, which was patented in December 2018. FeelTect was founded in May 2019 and in its first clinical investigation (July 2019), Tight Alright demonstrated a 6-fold improvement in targeted pressure achievement by experienced nurses. |
资金与预算
| 投资总额： | 600.0万美元 |
| 拟引投资总金额： | 100.0万美元 |
| 预计年销售收入： | 100.0万美元 |
| 预计投资收回期： | 3年 |
| 预计就业人数： | 10人 |
项目综合信息
| 项目优势条件： | n/a |
| 项目环保简述： | n/a |
| 投资者条件简述： | n/a |
单位和联系方式
Copyright © 2010-2018 All Rights Reserved
版权所有：中日韩企业双向投资促进公共服务平台
地址：中国威海市香港路18-1号智慧大厦701
联系电话：+86-631-5976515 / 5976516
鲁ICP备2022011968号-3 | 管理员登录
